Triple-negative breast cancer (TNBC) is a distinct, highly aggressive form of BC, characterized by lack of expression of the estrogen and progesterone receptors (ER/PR) as well as of human epidermal growth factor receptor 2 (HER2) in breast tumors [2]. This evidence concerns the gene ESR1 and breast cancer.